GREY:VIVXF - Post by User
Post by
gijo333on Feb 27, 2017 9:03am
95 Views
Post# 25897383
Avivagen grants options
Avivagen grants optionsOttawa, ON / TNW-Accesswire / February 27, 2017 / – Avivagen Inc. (TSXV: VIV, OTC Pink: CHEXF), a life sciences company commercializing products to replace the antibiotics used in livestock feeds, is accelerating market access and the commercial uptake of its OxC-beta™ Livestock product, an innovative product that has the potential to eliminate the use of antibiotics as growth promoters in livestock feed, a problem that needs an urgent solution and which represents a multi-billion dollar market.
The Company announces that it has granted options to purchase 800,000 common shares to employees, including an employee engaged in investor relations activities. The stock options were granted pursuant to the terms of Avivagen’s stock option plan and are exercisable at $0.10 per share. The options form part of the total remuneration package for the recipients. Stock option grants are subject to TSX Venture Exchange approval.